Display Settings:

Format

Send to:

Choose Destination
    Mol Genet Metab. 2010 Jun;100(2):149-54. Epub 2010 Mar 16.

    OPA3, mutated in 3-methylglutaconic aciduria type III, encodes two transcripts targeted primarily to mitochondria.

    Source

    Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892, USA. mhuizing@mail.nih.gov

    Abstract

    3-Methylglutaconic aciduria type III (3-MGCA type III), caused by recessive mutations in the 2-exon gene OPA3, is characterized by early-onset bilateral optic atrophy, later-onset extrapyramidal dysfunction, and increased urinary excretion of 3-methylglutaconic acid and 3-methylglutaric acid. Here we report the identification of a novel third OPA3 coding exon, the apparent product of a segmental duplication event, resulting in two gene transcripts, OPA3A and OPA3B. OPA3A deficiency (as in optic atrophy type 3) causes up-regulation of OPA3B. OPA3 protein function remains unknown, but it contains a putative mitochondrial leader sequence, mitochondrial sorting signal and a peroxisomal sorting signal. Our green fluorescent protein tagged OPA3 expression studies found its localization to be predominantly mitochondrial. These findings thus place the cellular metabolic defect of 3-MGCA type III in the mitochondrion rather than the peroxisome and implicate loss of OPA3A rather than gain of OPA3B in disease etiology.

    PMID:
    20350831
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC2872056
    Free PMC Article

    Images from this publication.See all images (2) Free text

    Fig. 2
    Fig. 1

      Supplemental Content

      Icon for Elsevier Science Icon for PubMed Central
      Write to the Help Desk